Search Results for "Resperate"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Resperate. Results 1 to 2 of 2 total matches.
See also: sevelamer

Resperate for Hypertension

   
The Medical Letter on Drugs and Therapeutics • Jul 02, 2007  (Issue 1264)
Resperate for Hypertension ...
The FDA has approved the marketing of Resperate (InterCure), a device that helps patients breathe slowly, as an adjunct for treatment of hypertension. The FDA does not require proof of effectiveness for approval of devices with minimal potential for harm, such as this one.
Med Lett Drugs Ther. 2007 Jul 2;49(1264):55-6 |  Show IntroductionHide Introduction

Correction: Resperate for Hypertension

   
The Medical Letter on Drugs and Therapeutics • Aug 27, 2007  (Issue 1268)
Correction: Resperate for Hypertension ...
(Med Lett Drugs Ther 2007; 49:55) The second sentence in the article ("The FDA does not require proof of effectiveness for approval of devices with minimal potential for harm, such as this one.") should have been omitted. It would apply to a Class I device, but the FDA has classified Resperate as a Class II device.
Med Lett Drugs Ther. 2007 Aug 27;49(1268):72 |  Show IntroductionHide Introduction